By Dr William Brooks

Conference Papers

Aguzzi A; Barbara J; Brown P; Budka H; Diringer H; Dormont D; Flanagan P; Heeschen W; Hope J; Hornlimann B; Kenney K; Masters C; Macnaughton MR; Pocchiari M; Rohwer RG; Safar J; Somogyi A; Tateishi J; Taylor D; Van Duijn CM; Wilesmith JW; Will R; Wisher M; Asher D; De Pedro J; Feek C; Hasebe K; Horaud F; Lower J; Minor P; Nandapalan P; Pavlov A; Perez AC; Ricketts M; Vicari G; Van Aken WG; Beal R; Menache-Aronson D; Bradley R; Bailey A; Chalumeau HP; Garland A; Brooks W; Schrieber R; Sprengers E; Andjaparidze AG; Bolis CL; Emmanuel JC; Griffiths E; Heymann DL; Kaboyo W; Meslin FX; Miyagawa S; Marroquin AP; Schudel A; Zeidler M, 1997, 'Medicinal and other products and human and animal transmissible spongiform encephalopathies: Memorandum from a WHO meeting', in Bulletin of the World Health Organization, pp. 505 - 513

Halliday GM; Brooks WS; Arthur HA; Creasey H; Broe T, 1997, 'Familial Alzheimer's disease, chromosome 21 and Parkinson's disease', in Brain Pathology, Int Society Neuropathology, Los Angeles, CA, USA, pp. 1369 - 1369, presented at XIIIth International Congress of Neuropathology, Perth, WA, 07 September 1997 - 12 September 1997

Halliday GM; Mccann H; Brooks WS; Broe T, 1997, 'Inflammation in Alzheimer's disease: anti-inflammatory medications increase post-mortem neuropathology', in Brain Pathology, Int Society Neuropathology, Los Angeles, CA, USA, pp. 1054 - 1054, presented at XIIIth International Congress of Neuropathology, Perth, WA, 07 September 1997 - 12 September 1997

Halliday GM; Mccann H; Brooks WS; Broe T, 1997, 'Inflammation in Alzheimer's disease: anti-inflammatory medications increase post-mortem neuropathology', in Andrews GR; Mykyta LJ; Andrews MM; Pearson SA; Gregory AJ; Hagger JC (eds.), 16th Congress of the International Association of Gerontology, Adelaide, Sth Aust, pp. 398 - 398, presented at 16th Congress of the International Association of Gerontology, Adelaide, Sth Aust, 19 August 1997 - 23 August 1997

Halliday GM; Brooks WS; Arthur HA; Nicholson GA; Yeung LM, 1997, 'Familial Alzheimer's disease, chromosome 21 and Parkinson's disease', in Journal of Clinical Neuroscience, Churchill Livingstone, Edinburgh, Midlothian, Scotland, pp. 386 - 387, presented at Australian Association of Neurologists Annual Scientific Meeting 1997, Sydney, 30 April 1997 - 02 May 1997

Conference Posters

Song YE; Halliday GM; Creasey H; Morris J; Brooks WS; Kril J, 2005, 'Neuropathology in the S305S Tau gene mutation', Vol. 238, pp. S302 - S302

Conference Abstracts

Bateman R; Aschenbrenner A; Benzinger T; Clifford D; Cruchaga C; Fagan A; Farlow M; Goate A; Gordon B; Hassenstab J; Jack C; Koeppe R; McDade E; Mills S; Morris JC; Salloway S; Santacruz A; Snyder P; Wang G; Xiong C; Snider BJ; Mummery C; Surti G; Didier H; Wallon D; Berman S; Lah J; Jimenez-Velazquez IZ; Roberson E; Van Dyck C; Honig LS; Valle RS; Brooks WS; Gauthier S; Masters C; Galasko D; Brosch J; Hsiung R; Jayadev S; Formaglio M; Masellis M; Clarnette R; Pariente J; Dubois B; Pasquier F; Andersen S; Holdridge K; Mintun M; Sims J; Yaari R; Baudler M; Delmar P; Doody R; Fountouro P; Kerchner G, 2020, 'DIAN-TU Alzheimer's Disease Prevention Trial of Solanezumab and Gantenerumab: Amyloid, Tau and Neurodegeneration Outcomes', in ANNALS OF NEUROLOGY, WILEY, ELECTR NETWORK, Vol. 88, pp. S103 - S103, presented at 145th Annual Meeting American-Neurological-Association, ELECTR NETWORK, 04 October 2020 - 09 October 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000572509100139&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Weickert T; Jacomb I; Lenroot R; Lappin J; Weinberg D; Brooks W; Brown D; Pellen D; Kindler J; Mohan A; Wakefield D; Lloyd A; Stanton C; O'Donnell M; Liu D; Galletly C; Weickert CS, 2019, 'Reduction in Peripheral C-Reactive Protein Levels With Canakinumab Administration is Related to Reduced Positive Symptom Severity in Patients With Schizophrenia and Inflammation', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, IL, Chicago, Vol. 85, pp. S44 - S45, presented at 74th Annual Meeting of the Society-of-Biological-Psychiatry (SOBP), IL, Chicago, 16 May 2019 - 18 May 2019, http://dx.doi.org/10.1016/j.biopsych.2019.03.121

Weickert T; Jacomb I; Lenroot R; Lappin J; Weinberg D; Brooks W; Brown D; Pellen D; Kindler J; Mohan A; Wakefield D; Lloyd A; Stanton C; O'Donnell M; Liu D; Galletly C; Weickert CS, 2019, 'REDUCTION IN PERIPHERAL C-REACTIVE PROTEIN LEVELS WITH CANAKINUMAB ADMINISTRATION IS RELATED TO REDUCED POSITIVE SYMPTOM SEVERITY IN PATIENTS WITH SCHIZOPHRENIA AND INFLAMMATION', in SCHIZOPHRENIA BULLETIN, OXFORD UNIV PRESS, FL, Orlando, Vol. 45, pp. S318 - S318, presented at Congress of the Schizophrenia-International-Research-Society (SRIS), FL, Orlando, 10 April 2019 - 14 April 2019, http://dx.doi.org/10.1093/schbul/sbz020.578

Dobson-Stone C; Shaw A; Brooks W; Loy C; Schofield P; Mather K; Kochan N; Sachdev P; Halliday G; Piguet O; Hodges J; Kwok J; Ittner L; Fath T; Housley G, 2015, 'Utility and challenges of whole-exome sequencing in the hunt for neurodegeneration genes [Abstract MTU02-05]', in Journal of Neurochemistry, Wiley: 12 months, Cairns, Australia, Vol. 134, pp. 111 - 111, presented at 25th Biennial Meeting of the International Society for Neurochemistry Jointly with the 13th Meeting of the Asian Pacific Society for Neurochemistry in Conjunction with the 35th Meeting of the Australasian Neuroscience Society, Cairns, Australia, 23 August 2015 - 27 August 2015, http://dx.doi.org/10.1111/jnc.13188

Preprints

Bateman RJ; Li Y; McDade EM; Llibre-Guerra JJ; Clifford DB; Atri A; Mills SL; Santacruz AM; Wang G; Supnet C; Benzinger TLS; Gordon BA; Ibanez L; Klein G; Baudler M; Doody RS; Delmar P; Kerchner GA; Bittner T; Wojtowicz J; Bonni A; Fontoura P; Hofmann C; Kulic L; Hassenstab J; Aschenbrenner AJ; Perrin RJ; Cruchaga C; Renton AE; Xiong C; Goate AA; Morris JC; Holtzman DM; Snider BJ; Mummery C; Brooks WS; Wallon D; Berman SB; Roberson E; Masters CL; Galasko DR; Jayadev S; Sanchez-Valle R; Pariente J; Kinsella J; van Dyck CH; Gauthier S; Robin Hsiung G-Y; Masellis M; Dubois B; Honig LS; Jack CR; Daniels A; Aguillón D; Allegri R; Chhatwal J; Day G; Fox N; Huey E; Ikeuchi T; Jucker M; Lee J-H; Levey AI; Levin J; Lopera F; Roh J; Rosa-Neto P; Schofield PR; Dominantly Inherited Alzheimer’s Disease-Trials Unit , 2025, Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU Trial., http://dx.doi.org/10.1101/2024.10.29.24316289

McKay NS; Gordon BA; Hornbeck RC; Jack CR; Koeppe R; Flores S; Keefe S; Hobbs DA; Joseph-Mathurin N; Wang Q; Rahmani F; Chen CD; McCullough A; Koudelis D; Chua J; Ances BM; Millar PR; Nickels M; Perrin RJ; Allegri RF; Berman SB; Brooks WS; Cash DM; Chhatwal JP; Farlow MR; Fox NC; Fulham M; Ghetti B; Graff-Radford N; Ikeuchi T; Day G; Klunk W; Levin J; Lee J-H; Martins R; Masters CL; McConathy J; Mori H; Noble JM; Rowe C; Salloway S; Sanchez-Valle R; Schofield PR; Shimada H; Shoji M; Su Y; Suzuki K; Vöglein J; Yakushev I; Swisher L; Cruchaga C; Hassenstab J; Karch C; McDade E; Xiong C; Morris JC; Bateman RJ; Benzinger TLS, 2022, Neuroimaging within the Dominantly Inherited Alzheimer’s Network (DIAN): PET and MRI, http://dx.doi.org/10.1101/2022.03.25.485799

Back to profile page